Carcinoembryonic Antigen (CEA)
| Clone | : | B01-94-11M-P |
| Isotype | : | IgG2b |
| Immunogen | : | Human Carcinoembryonic Antigen |
| Source | : | Mouse |
| Specificity | : | Carcinoembryonic antigen (CEA) |
| Protocol | : | 30 min @ RT |
| Tissue type | : | FFPE |
| Control tissue | : | COLON CARCINOMA |
| Pretreatment | : | None |
| Intended Use | : | IVD |
CEA consists of a heterogeneous family of related oncofetal 200 kD glycoproteins that is secreted into the glycocalyx surface of gastrointestinal cells. Usually CEA is demonstrated as a linear labeling of the apical poles of cells lining the glandular lumen and, occasionally, as weak staining near the apex of colonic epithelial cells. Pancreatic carcinomas, testicular tumor, gall bladder neoplasms and granular cell myoblastomas stain positive, whereas malignant tumors of brain, prostate, skin, lymphoreticular tissues, hepatocellular carcinomas, esophageal squamous cell carcinomas, and mesothelioma fail to stain for CEA . This antibody stains carcinoembryonic antigen in the cytoplasm of positive cells.
| Cat no. | Product Name | Pack size |
|---|---|---|
|
AM009-5M AM009-10M MU009-UC | Carcinoembryonic Antigen (CEA) |
6ml (Manual)
10ml (Automated) 1ml (Concentrated) |













